CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-02 | Markin Rodney S Director | Exercise or conversion | +16,667 | 22,610 | ||
| 2018-01-02 | Markin Rodney S Director | Exercise or conversion · Restricted Stock Units | −16,667 | 0 | ||
| 2017-10-04 | Tennant Stanley Director | Grant or award · Stock Options | +38,106 | 131,264 | ||
| 2017-10-04 | Markin Rodney S Director | Grant or award · Stock Options | +38,106 | 106,336 | ||
| 2017-10-04 | JACOB GARY S Director | Grant or award · Stock Options | +38,106 | 193,779 | ||
| 2017-10-04 | BRANCACCIO JOHN P Director | Grant or award · Stock Options | +38,106 | 191,808 | ||
| 2017-10-04 | Billings Paul Director | Grant or award · Stock Options | +38,106 | 121,336 | ||
| 2017-10-04 | ADAMS THOMAS PHD Director | Grant or award · Stock Options | +38,106 | 412,955 | ||
| 2017-09-05 | Tennant Stanley Director | Sale | −8,334 | $0.69 | $6K | 209,394 |
| 2017-09-02 | JACOB GARY S Director | Exercise or conversion | +9,287 | 132,287 | ||
| 2017-09-02 | JACOB GARY S Director | Exercise or conversion · Restricted Stock Units | −9,287 | 16,667 | ||
| 2017-09-02 | Tennant Stanley Director | Exercise or conversion | +8,484 | 217,878 | ||
| 2017-09-02 | Tennant Stanley Director | Exercise or conversion · Restricted Stock Units | −8,484 | 16,667 | ||
| 2017-09-02 | Billings Paul Director | Exercise or conversion | +6,498 | 6,498 | ||
| 2017-09-02 | Billings Paul Director | Exercise or conversion · Restricted Stock Units | −6,498 | 16,667 | ||
| 2017-09-02 | ADAMS THOMAS PHD Director | Exercise or conversion | +8,806 | 335,292 | ||
| 2017-09-02 | ADAMS THOMAS PHD Director | Exercise or conversion · Restricted Stock Units | −8,806 | 16,667 | ||
| 2017-09-02 | Erlander Mark Chief Scientific Officer | Exercise or conversion | +30,001 | 61,033 | ||
| 2017-09-02 | Erlander Mark Chief Scientific Officer | Shares withheld for taxes | −12,928 | 48,051 | ||
| 2017-09-02 | Erlander Mark Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −30,001 | 165,000 |
Page 13 of 15 · 299 trades